Al-Khair Gadoon Limited (PSX:AKGL)

Intercept Pharmaceuticals Ratios and Metrics

Market cap in millions PKR. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	570	324	280	279	153	151
Market Cap Growth	49.83%	15.57%	0.32%	83.02%	1.33%	150.83%
Enterprise Value	743	430	341	449	293	307
Last Close Price	57.00	32.36	28.00	27.91	15.25	15.05
PE Ratio	20.47	11.87	21.50	9.13	6.69	18.82
PS Ratio	0.42	0.25	0.26	0.24	0.19	0.34
PB Ratio	1.68	1.00	0.95	1.00	0.61	0.65
P/TBV Ratio	1.68	1.00	0.95	1.00	0.61	0.65
P/FCF Ratio	-	-	2.90	-	-	2.59
P/OCF Ratio	-	-	2.78	10.86	-	1.91
EV/Sales Ratio	0.54	0.34	0.32	0.39	0.37	0.70
EV/EBITDA Ratio	8.45	6.07	5.14	6.21	4.76	8.98
EV/EBIT Ratio	10.91	8.23	7.09	8.37	6.21	14.22
EV/FCF Ratio	-9.83	-	3.54	-	-	5.30
Debt / Equity Ratio	0.63	0.83	0.33	0.69	0.75	0.36
Debt / EBITDA Ratio	2.42	3.79	1.47	2.66	3.05	2.39
Debt / FCF Ratio	-	-	1.01	-	-	1.41
Asset Turnover	1.94	1.97	1.72	1.94	1.52	0.88
Inventory Turnover	3.18	3.40	3.04	3.41	2.74	1.80
Quick Ratio	0.15	0.21	0.25	0.25	0.26	0.24
Current Ratio	1.56	1.55	1.61	1.50	1.47	1.44
Return on Equity (ROE)	8.57%	8.82%	4.52%	11.49%	9.47%	3.54%
Return on Assets (ROA)	6.00%	5.03%	4.86%	5.61%	5.57%	2.72%
Return on Capital (ROIC)	8.36%	6.64%	6.95%	7.35%	7.85%	4.00%
Return on Capital Employed (ROCE)	18.50%	14.70%	14.50%	16.70%	16.30%	8.80%
Earnings Yield	4.89%	8.42%	4.65%	10.95%	14.96%	5.32%
FCF Yield	-13.26%	-46.05%	34.46%	-2.64%	-64.13%	38.57%
Payout Ratio	-	-	-	-	0.29%	-
Buyback Yield / Dilution	-0.28%	-	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.